Tempest Therapeutics, Inc.·4

Jan 10, 6:37 PM ET

Whiting Samuel 4

4 · Tempest Therapeutics, Inc. · Filed Jan 10, 2022

Insider Transaction Report

Form 4
Period: 2022-01-06
Whiting Samuel
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2022-01-06$4.80/sh+1,700$8,1681,901 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION